Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Elife|December 11, 2014
An open investigation of the reproducibility of cancer biology researchTimothy M Errington, Elizabeth Iorns, William Gunn, et al.
Peerj|April 24, 2018
Replication study: androgen receptor splice variants determine taxane sensitivity in prostate cancerXiaochuan Shan, Gwenn Danet-Desnoyers, Fraser Aird, et al.
Elife|December 7, 2021
Investigating the replicability of preclinical cancer biologyTimothy M Errington, Maya Mathur, Courtney K Soderberg, et al.
Peerj|September 25, 2015
Registered report: androgen receptor splice variants determine taxane sensitivity in prostate cancerXiaochuan Shan, Gwenn Danet-Desnoyers, Juan José Fung, et al.
Plos One|November 3, 2012
A new mouse model for the study of human breast cancer metastasisElizabeth Iorns, Katherine Drews-Elger, Toby M Ward, et al.
The EMBO Journal|April 5, 2008
A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitorNicholas C Turner, Christopher J Lord, Elizabeth Iorns, et al.
Breast Cancer Research and Treatment|October 24, 2012
PI3K independent activation of mTORC1 as a target in lapatinib-resistant ERBB2+ breast cancer cellsAnna-Maria Jegg, Toby M Ward, Elizabeth Iorns, et al.
Cancer Cell|February 5, 2008
Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancerElizabeth Iorns, Nicholas C Turner, Richard Elliott, et al.
The EMBO Journal|December 14, 2011
Rescue of tropomyosin deficiency in Drosophila and human cancer cells by synaptopodin reveals a role of tropomyosin α in RhoA stabilizationJenny S Wong, Elizabeth Iorns, Michelle N Rheault, et al.
Plos One|April 10, 2009
Integrated functional, gene expression and genomic analysis for the identification of cancer targetsElizabeth Iorns, Christopher J Lord, Anita Grigoriadis, et al.
Pageof 3